TAAR2

Across TCGA pan-cancer cohorts, TAAR2 RNA is linked to patient survival in 11 of 34 cancer types, making it the most broadly survival-associated TAAR2 data layer compared with 5 for mutation status.

The strongest signal is observed in stomach adenocarcinoma (STAD), where higher TAAR2 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated TAAR2 expression acts as an unfavorable survival marker.

STAD, OV, and TGCT are the cancer types where TAAR2 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
STAD	OS	Tertile	II,III,IV	0.463	0.738	.005	63	view →
OV	DFS	Tertile	All	0.336	0.543	.039	54	view →
TGCT	DFS	Tertile	II,III,IV	0.015	0.919	<.001	42	view →
LIHC	DFS	Tertile	III,IV	0.076	0.360	.001	36	view →
KIRC	DFS	Tertile	All	0.394	0.809	<.001	36	view →
BLCA	DFS	Tertile	III,IV	0.100	0.572	.002	18	view →
COAD	OS	Tertile	II,III,IV	0.116	0.643	.044	18	view →
DLBC	OS	Tertile	All	0.613	0.945	.049	9	view →
LGG	OS	Tertile	All	0.702	0.817	.023	6	view →
BRCA	OS	Tertile	All	0.883	0.964	.030	6	view →
ESCA	OS	Tertile	All	0.470	0.906	.017	3	view →

Pink = unfavorable, green = favorable. Showing the 11 strongest of 11 lineages.

TAAR2–STAD (OS)

Open the STAD breakdown →